CSF biomarker variability in the Alzheimer's Association quality control programNiklas Mattsson, Olivier Bousiges, Ulf Andréasson et al.|Alzheimer s & Dementia|2013Cited by 386
Tauopathy-like Abnormalities and Neurologic Deficits in Mice Immunized With Neuronal Tau ProteinHanna Rosenmann, Oded Abramsky, Nikolaos Grigoriadis et al.|Archives of Neurology|2006Cited by 177
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in miceMoran Boimel, Hanna Rosenmann, Nikolaos Grigoriadis et al.|Experimental Neurology|2010Cited by 174
Mitochondrial Transfer Ameliorates Cognitive Deficits, Neuronal Loss, and Gliosis in Alzheimer’s Disease MiceKeren Nitzan, Hanna Rosenmann, Sandrine Benhamron et al.|Journal of Alzheimer s Disease|2019Cited by 149
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy modelNatalia Shiryaev, Illana Gozes, Yan Jouroukhin et al.|Neurobiology of Disease|2009Cited by 122